Zebra Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-14,975
| Closed | -$148K | – | 89 |
|
|
2022
Q3 | $148K | Buy |
14,975
+209
| +1% | +$2.07K | 0.56% | 62 |
|
|
2022
Q2 | $161K | Sell |
14,766
-335
| -2% | -$3.65K | 0.47% | 79 |
|
|
2022
Q1 | $171K | Sell |
15,101
-4,258
| -22% | -$48.2K | 0.39% | 99 |
|
|
2021
Q4 | $304K | Sell |
19,359
-3,519
| -15% | -$55.3K | 0.49% | 68 |
|
|
2021
Q3 | $392K | Sell |
22,878
-7,008
| -23% | -$120K | 0.47% | 71 |
|
|
2021
Q2 | $642K | Sell |
29,886
-2,073
| -6% | -$44.5K | 0.75% | 45 |
|
|
2021
Q1 | $480K | Buy |
+31,959
| New | +$480K | 0.53% | 72 |
|
|
2019
Q4 | – | Sell |
-15,634
| Closed | -$208K | – | 320 |
|
|
2019
Q3 | $208K | Buy |
15,634
+3,582
| +30% | +$47.7K | 0.23% | 181 |
|
|
2019
Q2 | $170K | Buy |
+12,052
| New | +$170K | 0.09% | 417 |
|